Samuel J. White
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Samuel J. White has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan J. Juliano
University of North Carolina at Chapel Hill, Chapel Hill, USA
4 shared publications - Innocent Mbulli Ali
Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, Cameroon
3 shared publications - Rhoel R. Dinglasan
Department of Infectious Diseases and Immunology, College of Veterinary Medicine and Emerging Pathogens Institute, University of Florida , Gainesville, Florida
3 shared publications Claudia Gaither
Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill
2 shared publicationsDarlin B. N. Kaunda
Affiliation Department of Biochemistry, Faculty of Science, Université de Dschang, Dschang, West Region, Cameroon
2 shared publicationsEva M. Keming
Affiliation Department of Biochemistry, Faculty of Science, Université de Dschang, Dschang, West Region, Cameroon
2 shared publications
Latest Publications
- Open Access
- 24 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0340824
Distribution of falciparum and non-falciparum malaria among symptomatic malaria patients in Dschang, West Region of Cameroon
Background: Malaria is a vector-borne parasitic disease that continues to be a global public health threat. Five different species of the genus Plasmodium ( P. falciparum , P. malariae, P. ovale curtisi, P. ovale wallikeri, and P. vivax) cause malaria in Sub-Saharan Africa. Previous cross-sectional surveys from 2013 and 2017 indicated the circulation of P. vivax in the West region of Cameroon, prompting an investigation into the prevalence of all falciparum and non-falciparum malaria parasite species in this region. Methods: A cross-sectional facility-based study targeting both adult and children in which we recruited 431 clinically suspected cases of malaria from three health centres in the West region of Cameroon in 2020. Socio-demographic, clinical data, and dried blood spots (DBS) were collected from all consenting patients. Parasite DNA was extracted from DBS for real-time PCR amplification of species-specific Plasmodium 18S rRNA for P. falciparum, P. ovale, P. malariae, and P. vivax . In addition, P. ovale was further sub-classified into P. ovale curtisi or P. ovale wallikeri using qPCR. The prevalence of different species was measured. Results: Among the 431 samples, the overall malaria prevalence was 54.8% [95% CI: 50.1–59.8] (236/431). Of these, 53.4% [95% CI: 48.7–58.5] were infected with P. falciparum , 4% [95%CI: 2.2–5.6] with P. ovale , and 0.9% [95% CI: 0.2–1.7] with P. malariae . No P. vivax was detected. Mixed infections were common, with 8.9% of the infections harbouring more than one Plasmodium species. A total of 5 P. ovale and 1 P. malariae mono-infections were detected. Of the 17 P. ovale infections, 12 were successfully genotyped, with 6 P. ovale curtisi , 3 P. ovale wallikeri, and 3 a mixture of the species. Conclusions: While falciparum remains the dominant malaria parasite species among acute febrile illness cases, non-falciparum malaria is also commonly found in Dschang, both as a co-infection with P. falciparum and as mono-infections. Both subspecies of P. ovale are present in the region. Continued monitoring of non-falciparum species is needed for understanding malaria burden in West Cameroon.
- 24 February 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (2) , e0340824
Open AccessDistribution of falciparum and non-falciparum malaria among symptomatic malaria patients in Dschang, West Region of Cameroon
Background: Malaria is a vector-borne parasitic disease that continues to be a global public health threat. Five different species of the genus Plasmodium ( P. falciparum , P. malariae, P. ovale curtisi, P. ovale wallikeri, and P. vivax) cause malaria in Sub-Saharan Africa. Previous cross-sectional surveys from 2013 and 2017 indicated the circulation of P. vivax in the West region of Cameroon, prompting an investigation into the prevalence of all falciparum and non-falciparum malaria parasite species in this region. Methods: A cross-sectional facility-based study targeting both adult and children in which we recruited 431 clinically suspected cases of malaria from three health centres in the West region of Cameroon in 2020. Socio-demographic, clinical data, and dried blood spots (DBS) were collected from all consenting patients. Parasite DNA was extracted from DBS for real-time PCR amplification of species-specific Plasmodium 18S rRNA for P. falciparum, P. ovale, P. malariae, and P. vivax . In addition, P. ovale was further sub-classified into P. ovale curtisi or P. ovale wallikeri using qPCR. The prevalence of different species was measured. Results: Among the 431 samples, the overall malaria prevalence was 54.8% [95% CI: 50.1–59.8] (236/431). Of these, 53.4% [95% CI: 48.7–58.5] were infected with P. falciparum , 4% [95%CI: 2.2–5.6] with P. ovale , and 0.9% [95% CI: 0.2–1.7] with P. malariae . No P. vivax was detected. Mixed infections were common, with 8.9% of the infections harbouring more than one Plasmodium species. A total of 5 P. ovale and 1 P. malariae mono-infections were detected. Of the 17 P. ovale infections, 12 were successfully genotyped, with 6 P. ovale curtisi , 3 P. ovale wallikeri, and 3 a mixture of the species. Conclusions: While falciparum remains the dominant malaria parasite species among acute febrile illness cases, non-falciparum malaria is also commonly found in Dschang, both as a co-infection with P. falciparum and as mono-infections. Both subspecies of P. ovale are present in the region. Continued monitoring of non-falciparum species is needed for understanding malaria burden in West Cameroon.
- Open Access
Epidemiology of Relapsing and Falciparum Malaria in the Highlands of Cameroon: An Integrated Community Survey of Human Infection and Vector Abundance
Despite global malaria control efforts, the disease caused 263 million cases and 597,000 deaths in 2023. While Plasmodium falciparum accounts for most cases in Africa, non-falciparum species, such as P. ovale spp. and P. vivax , can cause relapse infections and are increasingly recognized as significant contributors to human disease. In particular, the highlands of West Cameroon have previously been reported to have high P. vivax infection rates. This study presents preliminary results from the Relapsing Malaria in Africa (ReMA) study, conducted in Dschang, Cameroon, to assess the prevalence and epidemiology of P. vivax and P. ovale . A cross-sectional survey of 3,661 participants from 871 households across seven health areas identified a low prevalence of P. vivax (0.1%) and P. ovale spp. (0.64%) using quantitative real time PCR (qPCR), while P. falciparum remained prevalent at 8.1%. Co-infections of P. ovale spp. with P. falciparum were observed in 23.1% of P. ovale spp. cases. While gametocytemia was common among falciparum infections, leveraging a new ovale gametocyte assay, we found that gametocytemia was uncommon among the qPCR-positive ovale infections. Spatial analysis found P. vivax and P. ovale spp. infections concentrated in Penka-Michel and Baleveng, the former having higher Anopheles spp. abundance than other areas assessed. Risk factor analysis revealed children and those with recent domestic travel had higher odds of P. falciparum infection, but no significant associations were found for P. ovale spp. infections. Entomological surveys confirmed high densities of Anopheles gambiae sensu lato ( s.l. ) and An. funestus (s.l.), with significantly higher human landing capture rates for An. gambiae s.l compared to other mosquito species. While these findings suggest that the relapsing malarias are not as widespread as previously thought in West Cameroon, understanding factors driving their persistent transmission, especially without prevalent gametocytemia, will be important for disease control. AUTHOR SUMMARY: Malaria caused 263 million cases and 597,000 deaths in 2023, with most cases in Africa due to Plasmodium falciparum . However, the dangers of other species like P. ovale and P. vivax , which can cause relapsing infections, are becoming more clear in Africa. The Relapsing Malaria in Africa (ReMA) study in Dschang, Cameroon, surveyed 3,661 people from 871 households to better understand these infections. Results showed low rates of P. vivax (0.1%) and P. ovale (0.64%) compared to P. falciparum (8.1%). Infections were more common in areas with high mosquito abundance and biting activity. While the relapsing malarias were less common than expected, understanding factors driving their persistent transmission, especially without prevalent gametocytemia, will be important for disease control.
Open AccessEpidemiology of Relapsing and Falciparum Malaria in the Highlands of Cameroon: An Integrated Community Survey of Human Infection and Vector Abundance
Despite global malaria control efforts, the disease caused 263 million cases and 597,000 deaths in 2023. While Plasmodium falciparum accounts for most cases in Africa, non-falciparum species, such as P. ovale spp. and P. vivax , can cause relapse infections and are increasingly recognized as significant contributors to human disease. In particular, the highlands of West Cameroon have previously been reported to have high P. vivax infection rates. This study presents preliminary results from the Relapsing Malaria in Africa (ReMA) study, conducted in Dschang, Cameroon, to assess the prevalence and epidemiology of P. vivax and P. ovale . A cross-sectional survey of 3,661 participants from 871 households across seven health areas identified a low prevalence of P. vivax (0.1%) and P. ovale spp. (0.64%) using quantitative real time PCR (qPCR), while P. falciparum remained prevalent at 8.1%. Co-infections of P. ovale spp. with P. falciparum were observed in 23.1% of P. ovale spp. cases. While gametocytemia was common among falciparum infections, leveraging a new ovale gametocyte assay, we found that gametocytemia was uncommon among the qPCR-positive ovale infections. Spatial analysis found P. vivax and P. ovale spp. infections concentrated in Penka-Michel and Baleveng, the former having higher Anopheles spp. abundance than other areas assessed. Risk factor analysis revealed children and those with recent domestic travel had higher odds of P. falciparum infection, but no significant associations were found for P. ovale spp. infections. Entomological surveys confirmed high densities of Anopheles gambiae sensu lato ( s.l. ) and An. funestus (s.l.), with significantly higher human landing capture rates for An. gambiae s.l compared to other mosquito species. While these findings suggest that the relapsing malarias are not as widespread as previously thought in West Cameroon, understanding factors driving their persistent transmission, especially without prevalent gametocytemia, will be important for disease control. AUTHOR SUMMARY: Malaria caused 263 million cases and 597,000 deaths in 2023, with most cases in Africa due to Plasmodium falciparum . However, the dangers of other species like P. ovale and P. vivax , which can cause relapsing infections, are becoming more clear in Africa. The Relapsing Malaria in Africa (ReMA) study in Dschang, Cameroon, surveyed 3,661 people from 871 households to better understand these infections. Results showed low rates of P. vivax (0.1%) and P. ovale (0.64%) compared to P. falciparum (8.1%). Infections were more common in areas with high mosquito abundance and biting activity. While the relapsing malarias were less common than expected, understanding factors driving their persistent transmission, especially without prevalent gametocytemia, will be important for disease control.
- Open Access
Distribution of non-falciparum malaria among symptomatic malaria patients in Dschang, West Region of Cameroon
Background: Malaria is a vector-borne parasitic disease that continues to be a global public health threat. Five different species of the genus Plasmodium ( P. falciparum, P. malariae, P. ovale curtisi, P. ovale wallikeri , and P. vivax) cause malaria in Sub-Saharan Africa. Previous cross-sectional surveys from 2013 and 2017 indicated the circulation of P. vivax in the West region of Cameroon, prompting an investigation into the prevalence of all non-falciparum malaria parasite species in this region. Methods: A cross-sectional facility-based study recruited 431 clinically suspected cases of malaria from three health centres in the West region of Cameroon in 2020. Socio-demographic, clinical data, and dried blood spots (DBS) were collected from all consenting patients. Parasite DNA was extracted from DBS for real-time PCR amplification of species-specific Plasmodium 18S rRNA for P. falciparum, P. ovale, P. malariae, and P. vivax . In addition, P. ovale was further sub-classified into P. ovale curtisi or P. ovale wallikeri . The prevalence of different species was measured. Results: Among the 431 samples, the overall malaria prevalence was 54.8% (236/431). Of these, 49.9% were infected with P. falciparum , 4% with P. ovale , and 0.9% with P. malariae . No P. vivax was detected. Mixed infections were common, with 3.5% of the infections harbouring more than one Plasmodium species. A total of 5 P. ovale and 1 P. malariae mono-infections were detected. Of the 17 P. ovale infections, 12 were successfully genotyped, with 6 P. ovale curtisi , 3 P. ovale wallikeri, and 3 mixture of the species. Conclusions: While falciparum remains the dominant malaria parasite species among acute febrile illness cases, non-falciparum malaria is also commonly found in Dschang, both as a co-infection with P. falciparum and as mono-infections. Both subspecies of P. ovale are present in the region. Continued monitoring of non-falciparum species is needed for understanding malaria burden in West Cameroon.
Open AccessDistribution of non-falciparum malaria among symptomatic malaria patients in Dschang, West Region of Cameroon
Background: Malaria is a vector-borne parasitic disease that continues to be a global public health threat. Five different species of the genus Plasmodium ( P. falciparum, P. malariae, P. ovale curtisi, P. ovale wallikeri , and P. vivax) cause malaria in Sub-Saharan Africa. Previous cross-sectional surveys from 2013 and 2017 indicated the circulation of P. vivax in the West region of Cameroon, prompting an investigation into the prevalence of all non-falciparum malaria parasite species in this region. Methods: A cross-sectional facility-based study recruited 431 clinically suspected cases of malaria from three health centres in the West region of Cameroon in 2020. Socio-demographic, clinical data, and dried blood spots (DBS) were collected from all consenting patients. Parasite DNA was extracted from DBS for real-time PCR amplification of species-specific Plasmodium 18S rRNA for P. falciparum, P. ovale, P. malariae, and P. vivax . In addition, P. ovale was further sub-classified into P. ovale curtisi or P. ovale wallikeri . The prevalence of different species was measured. Results: Among the 431 samples, the overall malaria prevalence was 54.8% (236/431). Of these, 49.9% were infected with P. falciparum , 4% with P. ovale , and 0.9% with P. malariae . No P. vivax was detected. Mixed infections were common, with 3.5% of the infections harbouring more than one Plasmodium species. A total of 5 P. ovale and 1 P. malariae mono-infections were detected. Of the 17 P. ovale infections, 12 were successfully genotyped, with 6 P. ovale curtisi , 3 P. ovale wallikeri, and 3 mixture of the species. Conclusions: While falciparum remains the dominant malaria parasite species among acute febrile illness cases, non-falciparum malaria is also commonly found in Dschang, both as a co-infection with P. falciparum and as mono-infections. Both subspecies of P. ovale are present in the region. Continued monitoring of non-falciparum species is needed for understanding malaria burden in West Cameroon.
- Open Access
Baseline characteristics for phase II of the Kinshasa Malaria Cohort Study: cohort profile
Purpose The Democratic Republic of Congo has one of the highest burdens of malaria in the world, accounting for 12.3% of malaria cases and 11.6% of malaria deaths. The country has been scaling up various malaria control interventions, but how the malaria burden and risk factors have evolved remains unclear. This study aimed to estimate the trend in the burden of malaria in different settings in Kinshasa Province and assess factors contributing to the infection. Participants From 2018 to 2022, a cohort study was conducted in three health areas in Kinshasa Province known to have varying malaria endemicities: Voix du Peuple (urban), Kimpoko (peri-urban), and Bu (rural) health areas in Kinshasa Province. Participants 6 months of age and older were recruited and followed biannually through household visits and encouraged to visit study health centres whenever they felt ill. The participants’ sociodemographic data, illness history and access to malaria interventions were collected along with blood specimens. During the same study period, mosquitoes and larvae were collected to study entomological characteristics that may contribute to malaria transmission. Findings A total of 1635 participants were recruited from 239 households. The median number of participants per household was 6 (IQR, 5–9). Over half (54.7%) of the participants were female, 14.6% were under-5 children, and 33.3% were 5–14 years old. Household net ownership and reported use the previous night were 77.8% and 79.1%, respectively. Overall, malaria prevalence by rapid diagnostic test at baseline was 33.4%. Of the recruited participants, 1390 (85%) completed the 4 years of follow-up. Future plans Planned analyses include calculating malaria prevalence and incidence trends at follow-up as well as risk factors for infection. Continued analyses will link epidemiological and entomological data to understand malaria transmission evolution and the sustained high prevalence of malaria over time in various settings.
Open AccessBaseline characteristics for phase II of the Kinshasa Malaria Cohort Study: cohort profile
Purpose The Democratic Republic of Congo has one of the highest burdens of malaria in the world, accounting for 12.3% of malaria cases and 11.6% of malaria deaths. The country has been scaling up various malaria control interventions, but how the malaria burden and risk factors have evolved remains unclear. This study aimed to estimate the trend in the burden of malaria in different settings in Kinshasa Province and assess factors contributing to the infection. Participants From 2018 to 2022, a cohort study was conducted in three health areas in Kinshasa Province known to have varying malaria endemicities: Voix du Peuple (urban), Kimpoko (peri-urban), and Bu (rural) health areas in Kinshasa Province. Participants 6 months of age and older were recruited and followed biannually through household visits and encouraged to visit study health centres whenever they felt ill. The participants’ sociodemographic data, illness history and access to malaria interventions were collected along with blood specimens. During the same study period, mosquitoes and larvae were collected to study entomological characteristics that may contribute to malaria transmission. Findings A total of 1635 participants were recruited from 239 households. The median number of participants per household was 6 (IQR, 5–9). Over half (54.7%) of the participants were female, 14.6% were under-5 children, and 33.3% were 5–14 years old. Household net ownership and reported use the previous night were 77.8% and 79.1%, respectively. Overall, malaria prevalence by rapid diagnostic test at baseline was 33.4%. Of the recruited participants, 1390 (85%) completed the 4 years of follow-up. Future plans Planned analyses include calculating malaria prevalence and incidence trends at follow-up as well as risk factors for infection. Continued analyses will link epidemiological and entomological data to understand malaria transmission evolution and the sustained high prevalence of malaria over time in various settings.
- Open Access
Prevalence of Asymptomatic non-Falciparum and Falciparum Malaria in the 2014-15 Rwanda Demographic Health Survey
Background: Recent molecular surveillance suggests an unexpectedly high prevalence of non-falciparum malaria in Africa. Malaria control is also challenged by undetected asymptomatic P. falciparum malaria resulting in an undetectable reservoir for potential transmission. Context-specific surveillance of asymptomatic P. falciparum and non-falciparum species is needed to properly inform malaria control programs. Methods: We performed quantitative real time PCR for four malaria species in 5,050 primarily adult individuals in Rwanda using the 2014-2015 Demographic Health Survey. We assessed correlates of infection by species to explore attributes associated with each species. Asymptomatic P. ovale spp ., P. malariae, and P. falciparum malaria infection had broad spatial distribution across Rwanda. P. vivax infection was rare. Results: Overall infection prevalence was 22.3% (95%CI [20.3, 24.3]), with P. falciparum and non-falciparum at 16.3% [14.5, 18.1] and 8.0% [6.6, 9.3], respectively. Parasitemias tended to be low and mixed species infections were common, especially where malaria transmission and overall prevalence was the highest. P. falciparum infection was associated with lower wealth, rural residence and low elevation. Fewer factors were significantly associated with non-falciparum malaria. Conclusions: Asymptomatic non-falciparum malaria and P. falciparum malaria are common and widely distributed across Rwanda in adults. Continued molecular monitoring, preferably done by the national malaria control program, of Plasmodium diversity using routine survey samples is needed to strengthen malaria control.
Open AccessPrevalence of Asymptomatic non-Falciparum and Falciparum Malaria in the 2014-15 Rwanda Demographic Health Survey
Background: Recent molecular surveillance suggests an unexpectedly high prevalence of non-falciparum malaria in Africa. Malaria control is also challenged by undetected asymptomatic P. falciparum malaria resulting in an undetectable reservoir for potential transmission. Context-specific surveillance of asymptomatic P. falciparum and non-falciparum species is needed to properly inform malaria control programs. Methods: We performed quantitative real time PCR for four malaria species in 5,050 primarily adult individuals in Rwanda using the 2014-2015 Demographic Health Survey. We assessed correlates of infection by species to explore attributes associated with each species. Asymptomatic P. ovale spp ., P. malariae, and P. falciparum malaria infection had broad spatial distribution across Rwanda. P. vivax infection was rare. Results: Overall infection prevalence was 22.3% (95%CI [20.3, 24.3]), with P. falciparum and non-falciparum at 16.3% [14.5, 18.1] and 8.0% [6.6, 9.3], respectively. Parasitemias tended to be low and mixed species infections were common, especially where malaria transmission and overall prevalence was the highest. P. falciparum infection was associated with lower wealth, rural residence and low elevation. Fewer factors were significantly associated with non-falciparum malaria. Conclusions: Asymptomatic non-falciparum malaria and P. falciparum malaria are common and widely distributed across Rwanda in adults. Continued molecular monitoring, preferably done by the national malaria control program, of Plasmodium diversity using routine survey samples is needed to strengthen malaria control.
- 19 December 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (12) , e0073123
The clinical epidemiology, management, and outcomes of patients diagnosed with encephalitis in North Carolina, 2015–2020
Historically, the underlying cause of encephalitis was often not identified, even though the condition was responsible for substantial morbidity and mortality. The past decade, however, has witnessed the establishment of consensus case definitions and management guidelines, accompanied by rapid advances in molecular diagnostic techniques. The objective of this study was to describe the epidemiology of and routine care practices for patients diagnosed with encephalitis at a large academic tertiary referral hospital. A retrospective analysis of adults and children admitted to the University of North Carolina Medical Center between 2015 and 2020 was conducted. Cases of interest were identified by ICD9 and ICD10 codes with a diagnosis of encephalitis confirmed through record review. One-third (82, 31.6%) of the cohort did not have a lumbar puncture performed. Of the 177 patients who had a diagnostic lumbar puncture performed, 87 (49.2%) cases were a result of a confirmed infectious pathogen. Herpes simplex virus (HSV)-1 ( n = 9) and HSV-2 ( n = 12) were the most common infectious causes, followed by varicella zoster virus (VZV) ( n = 16) and Toxoplasma gondii ( n = 5). There were no confirmed cases of enterovirus or arboviral diseases, but less than half of patients were tested for these pathogens. The case fatality rate was 10.7% ( n = 19) overall and 12.6% ( n = 11) in those with infectious causes. Despite advances in diagnostics, a high proportion of cases ( n = 75, 42.0%) were still classified as idiopathic. The use of order sets and/or multiplex testing (i.e., “encephalitis panel”) may improve the diagnosis of infectious encephalitis. IMPORTANCE: Despite the relatively high mortality and the difficulty in diagnosis, nearly one-third of patients hospitalized with a documented diagnosis of encephalitis did not undergo a lumbar puncture (LP). When an LP was performed, pathogen-specific testing was greatly underutilized. Infectious etiologies were most common, but over 40% of cases were idiopathic at discharge. These findings suggest that there is a substantial opportunity to improve the quality of care through more accurate and timely diagnosis.
- 19 December 2023
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (12) , e0073123
The clinical epidemiology, management, and outcomes of patients diagnosed with encephalitis in North Carolina, 2015–2020
Historically, the underlying cause of encephalitis was often not identified, even though the condition was responsible for substantial morbidity and mortality. The past decade, however, has witnessed the establishment of consensus case definitions and management guidelines, accompanied by rapid advances in molecular diagnostic techniques. The objective of this study was to describe the epidemiology of and routine care practices for patients diagnosed with encephalitis at a large academic tertiary referral hospital. A retrospective analysis of adults and children admitted to the University of North Carolina Medical Center between 2015 and 2020 was conducted. Cases of interest were identified by ICD9 and ICD10 codes with a diagnosis of encephalitis confirmed through record review. One-third (82, 31.6%) of the cohort did not have a lumbar puncture performed. Of the 177 patients who had a diagnostic lumbar puncture performed, 87 (49.2%) cases were a result of a confirmed infectious pathogen. Herpes simplex virus (HSV)-1 ( n = 9) and HSV-2 ( n = 12) were the most common infectious causes, followed by varicella zoster virus (VZV) ( n = 16) and Toxoplasma gondii ( n = 5). There were no confirmed cases of enterovirus or arboviral diseases, but less than half of patients were tested for these pathogens. The case fatality rate was 10.7% ( n = 19) overall and 12.6% ( n = 11) in those with infectious causes. Despite advances in diagnostics, a high proportion of cases ( n = 75, 42.0%) were still classified as idiopathic. The use of order sets and/or multiplex testing (i.e., “encephalitis panel”) may improve the diagnosis of infectious encephalitis. IMPORTANCE: Despite the relatively high mortality and the difficulty in diagnosis, nearly one-third of patients hospitalized with a documented diagnosis of encephalitis did not undergo a lumbar puncture (LP). When an LP was performed, pathogen-specific testing was greatly underutilized. Infectious etiologies were most common, but over 40% of cases were idiopathic at discharge. These findings suggest that there is a substantial opportunity to improve the quality of care through more accurate and timely diagnosis.
- 30 May 2020
- Published by BMJ in BMJ Military Health
- Vol. 166 (6) , 418-420
Command application of UK military climatic guidance on Exercise SAIF SAREEA 3
Health and risk management of personnel in hot climates remains a Commander’s responsibility, with Joint Service Publication 539 Heat Illness and Cold Injury: Prevention and Management (JSP 539) being the guiding document for the UK military. This policy can be challenging to interpret occasionally, needing medical professionals to provide ongoing advice to commanders. This is to achieve a shared understanding of scientific concepts and risks to allow a more informed decision-making by commanders. This then leads to the appropriate mitigation of risks to as low as reasonably practical. Exercise SAIF SAREEA 3 saw commanders and medical cooperation at all levels with a practical and pragmatic application of the principles articulated in joint policy. The elements which saw enhanced cooperation included pathophysiology, work rates and work:rest ratios, rest and sleep periods, uniform, acclimatisation, and hydration and electrolyte balance. This approach was exhibited throughout the planning, deployment and execution of Exercise SAIF SAREEA 3, which saw extremely low levels of heat injury throughout the exercise when compared with SAIF SAREEA 2 and related exercises. This personal view aims to describe the command and medical interaction on SAIF SAREEA 3 which the authors feel contributed to those successes against climatic effects.
- 30 May 2020
- Published by BMJ in BMJ Military Health
- Vol. 166 (6) , 418-420
Command application of UK military climatic guidance on Exercise SAIF SAREEA 3
Health and risk management of personnel in hot climates remains a Commander’s responsibility, with Joint Service Publication 539 Heat Illness and Cold Injury: Prevention and Management (JSP 539) being the guiding document for the UK military. This policy can be challenging to interpret occasionally, needing medical professionals to provide ongoing advice to commanders. This is to achieve a shared understanding of scientific concepts and risks to allow a more informed decision-making by commanders. This then leads to the appropriate mitigation of risks to as low as reasonably practical. Exercise SAIF SAREEA 3 saw commanders and medical cooperation at all levels with a practical and pragmatic application of the principles articulated in joint policy. The elements which saw enhanced cooperation included pathophysiology, work rates and work:rest ratios, rest and sleep periods, uniform, acclimatisation, and hydration and electrolyte balance. This approach was exhibited throughout the planning, deployment and execution of Exercise SAIF SAREEA 3, which saw extremely low levels of heat injury throughout the exercise when compared with SAIF SAREEA 2 and related exercises. This personal view aims to describe the command and medical interaction on SAIF SAREEA 3 which the authors feel contributed to those successes against climatic effects.